About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Kubota Pharmaceutical Holdings Co., Ltd.(4596) Financial Results

4596
TSE Growth
Kubota Pharmaceutical Holdings Co., Ltd.
51
JPY
+1
(+2.00%)
Jan 10, 3:30 pm JST
0.32
USD
Jan 10, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2020 38 -2,484 -2,437 -2,437 -56.9 0 Feb 12, 2021 IFRS
Dec, 2021 0 -2,585 -2,616 -2,616 -57.5 0 Feb 14, 2022 IFRS
Dec, 2022 8 -2,038 -2,016 -2,016 -40.9 0 Feb 14, 2023 IFRS
Dec, 2023 40 -1,504 -1,490 -1,490 -26.8 0 Feb 14, 2024 IFRS
Dec, 2024 Guidance 0 Feb 14, 2024 IFRS
YoY
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 846 0 -1 -1 0.0
Fiscal Year Dec, 2016 Dec, 2015 Dec, 2015 Dec, 2015 Dec, 2015
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2021 0 -1,250 -1,265 -1,265 -27.8 0 Feb 14, 2022 IFRS
Jul - Dec, 2022 8 -866 -819 -819 -16.6 0 Feb 14, 2023 IFRS
Jul - Dec, 2023 23 -757 -745 -745 -13.4 0 Feb 14, 2024 IFRS
Jul - Dec, 2024 Guidance 0 Feb 14, 2024 IFRS
YoY
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Dec, 2021 -2,585 1,049 -2,513 3,562 171 3,977 82.31 IFRS
Dec, 2022 -2,038 -1,581 -2,086 505 1,446 4,048 91.60 IFRS
Dec, 2023 -1,504 -1,380 -1,335 -45 96 2,767 91.74 IFRS
Actual Performance and Financial Trends
Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 3 -1,653 -1,681 -1,681 -35.2 Nov 11, 2022 IFRS
Jan - Sep, 2023 31 -1,031 -1,027 -1,027 -18.5 Nov 14, 2023 IFRS
Jan - Sep, 2024 17 -955 -1,000 -1,000 -17.8 Nov 14, 2024 IFRS
YoY -45.2% +7.4% +2.6% +2.6% +4.2%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 5 -385 -335 -335 -6.8 -7,700.0 Feb 14, 2023 IFRS
Jan - Mar, 2023 5 -445 -444 -444 -8.1 -8,900.0 May 12, 2023 IFRS
Apr - Jun, 2023 12 -302 -301 -301 -5.5 -2,516.7 Aug 10, 2023 IFRS
Jul - Sep, 2023 14 -284 -282 -282 -5.1 -2,028.6 Nov 14, 2023 IFRS
Oct - Dec, 2023 9 -473 -463 -463 -8.3 -5,255.6 Feb 14, 2024 IFRS
Jan - Mar, 2024 5 -337 -343 -343 -6.1 -6,740.0 May 14, 2024 IFRS
Apr - Jun, 2024 5 -338 -326 -326 -5.8 -6,760.0 Aug 14, 2024 IFRS
Jul - Sep, 2024 7 -280 -331 -331 -5.9 -4,000.0 Nov 14, 2024 IFRS
YoY -50.0% +1.4% -17.4% -17.4% -15.5%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 73 -280 -282 -282 -5.1
Fiscal Year Sep, 2016 Sep, 2024 Sep, 2023 Sep, 2023 Sep, 2023
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Dec, 2021 90.55 85.9 4,832 4,152 -22,164 0.05 Feb 14, 2022 IFRS
Dec, 2022 72.31 89.4 4,419 3,949 -24,180 0.04 Feb 14, 2023 IFRS
Dec, 2023 47.21 87.7 3,016 2,646 -25,670 0.05 Feb 14, 2024 IFRS
Jan - Sep, 2024 88.1 1,923 1,695 -24,723 0.04 Nov 14, 2024 IFRS